Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HSD17B12 pseudogene 1 (HSD17B12P1) is a pseudogene identified in the genome of certain mouse strains (notably BALB/c) but not in humans[1]. It is related to the active HSD17B12 gene, which encodes hydroxysteroid (17-beta) dehydrogenase 12, an enzyme critical for estrone-to-estradiol conversion and fatty acid elongation[2][3][5]. The pseudogene can encode variant peptides expressed in some mouse tumors but shows no evidence of functional importance or expression in normal physiology or human disease[1]. Because HSD17B12P1 is neither active in humans nor associated with drugs or therapeutics, it should not be considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HSD17B12 pseudogene 1 (HSD17B12P1).